A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4 -dose Regimen of V114 in Healthy Infants (PNEU-PED)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/25/19 → 4/24/23

Funding

  • Merck Sharp and Cohme Corporation: $6,000.00